The impact of nontuberculous mycobacterial lung disease in critically ill patients: significance for survival and ventilator use

Ying-Chun Chien,Chin-Hao Chang,Chun-Kai Huang,Yung-Hsuan Chen,Chia-Jung Liu,Chung-Yu Chen,Ping-Huai Wang,Chin-Chung Shu,Lu-Cheng Kuo,Jann-Yuan Wang,Shih-Chi Ku,Hao-Chien Wang,Chong-Jen Yu
DOI: https://doi.org/10.1016/j.jmii.2023.12.009
IF: 10.273
2024-01-07
Journal of Microbiology Immunology and Infection
Abstract:Background This study investigates the impact of nontuberculous mycobacterial lung disease (NTM-LD) on mortality and mechanical ventilation use in critically ill patients. Methods We enrolled patients with NTM-LD or tuberculosis (TB) in intensive care units (ICU) and analysed their association with 30-day mortality and with mechanical ventilator-free survival (VFS) at 30 days after ICU admission. Results A total of 5,996 ICU-admitted patients were included, of which 541 (9.0%) had TB and 173 (2.9%) had NTM-LD. The overall 30-day mortality was 22.2%. The patients with NTM-LD had an adjusted hazard ratio (aHR) of 1.49 (95% CI, 1.06–2.05), and TB patients had an aHR of 2.33 (95% CI, 1.68–3.24), compared to ICU patients with negative sputum mycobacterial culture by multivariable Cox proportional hazard (PH) regression. The aHR of age<65 years, obesity, idiopathic pulmonary fibrosis, end-stage kidney disease, active cancer and autoimmune disease and diagnosis of respiratory failure were also significantly positively associated with ICU 30-day mortality. In multivariable Cox PH regression for VFS at 30 days in patients requiring invasive mechanical ventilation, NTM-LD was negatively associated with VFS (aHR 0.71, 95% CI: 0.56–0.92, p =0.009), while TB showed no significant association. The diagnosis of respiratory failure itself predicted unfavourable outcome for 30-day mortality and a negative impact on VFS at 30 days. Conclusions NTM-LD and TB were not uncommon in ICU and both were correlated with increasing 30-day mortality in ICU patients. NTM-LD was associated with a poorer outcome in terms of VFS at 30 days.
immunology,infectious diseases,microbiology
What problem does this paper attempt to address?